This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Neuroprotection by MC1R as the basis for the melanoma-Parkinsons disease link Investments < €500k United States of America 2016
Design and development of a mixed reality system for skilled locomotor training in individuals with Parkinsons disease Investments < €500k United States of America 2016
Roles of heat shock protein 110 in modulating amyloid neurotoxicity Investments < €500k United States of America 2016
Genetic Susceptibility to Manganese Neurotoxicity Investments < €500k United States of America 2016
A new approach to modeling ALS based on TBK1 mutation in mice Investments < €500k United States of America 2016
Modulating the Nucleopathy caused by FUS Mutants of ALS Investments < €500k United States of America 2016
A new antibody/RNAi combination therapy strategy for ALS Investments < €500k United States of America 2016
Investigating the response of FUS/TLS to excitotoxic insult Investments < €500k United States of America 2016
Does TDP-43 dysfunction in astrocytes trigger motor neuron degeneration? Investments < €500k United States of America 2016
SYNJ1 Mediates a Novel Signaling Pathway in Parkinsons Disease Investments < €500k United States of America 2016
